Bright Minds Biosciences Inc. (CSE:DRUG)
Canada · Delayed Price · Currency is CAD 115.66
-3.23 (-2.72%)
Apr 10, 2026, 1:31 PM EST
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of CAD 1.13 billion as of April 10, 2026. Its market cap has increased by 198.70% in one year.
Market Cap
1.13B
Enterprise Value
1.04B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
115.66
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from 53.34M to 1.13B, an increase of 2,022.39%. That is a compound annual growth rate of 80.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 1.16B | 35.31% |
| Dec 31, 2025 | 859.94M | 138.45% |
| Dec 31, 2024 | 360.63M | 3,710.83% |
| Dec 29, 2023 | 9.46M | -50.41% |
| Dec 30, 2022 | 19.08M | -60.52% |
| Dec 31, 2021 | 48.34M | -9.37% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 599.66M |
| Satellos Bioscience | 179.36M |
| Helix BioPharma | 143.59M |
| ME Therapeutics Holdings | 75.12M |
| Sharp Therapeutics | 64.66M |
| Sernova Biotherapeutics | 63.26M |
| NurExone Biologic | 57.99M |
| Medicenna Therapeutics | 52.55M |